74.32

1.11% -0.83

Boston Scientific Corp (BSX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$75.15

Aprire:

$74.81

Volume 24 ore:

7.55M

Relative Volume:

0.57

Capitalizzazione di mercato:

$110.30B

Reddito:

$20.08B

Utile/perdita netta:

$2.89B

Rapporto P/E:

38.33

EPS:

1.9391

Flusso di cassa netto:

$3.66B

1 W Prestazione:

-2.57%

1M Prestazione:

-19.67%

6M Prestazione:

-29.30%

1 anno Prestazione:

-26.21%

Intervallo 1D:

$74.08

$74.91

Intervallo di 1 settimana:

$73.81

$76.87

Portata 52W:

$72.69

$109.50

Boston Scientific Corp Stock (BSX) Company Profile

Nome

Boston Scientific Corp

Settore

Healthcare (1117)

Industria

Medical Devices (142)

Telefono

508-683-4000

Indirizzo

300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA

Dipendente

59,000

Cinguettio

@bostonsci

Prossima data di guadagno

2025-10-22

Ultimi documenti SEC

BSX's Discussions on Twitter

Compare BSX vs ABT, SYK, MDT, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BSX Boston Scientific Corp	74.33	111.51B	20.08B	2.89B	3.66B	1.9391
ABT Abbott Laboratories	114.77	199.24B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	384.11	145.93B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	96.92	124.03B	35.48B	4.64B	5.41B	3.5856
EW Edwards Lifesciences Corp	83.65	47.82B	6.07B	1.06B	799.60M	1.8527

Boston Scientific Corp Stock (BSX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-10-03	Downgrade	Erste Group	Buy → Hold
2025-09-08	Aggiornamento	Oppenheimer	Perform → Outperform
2025-06-16	Iniziato	Leerink Partners	Outperform
2025-04-16	Aggiornamento	Needham	Hold → Buy
2025-01-10	Aggiornamento	Deutsche Bank	Hold → Buy
2024-10-18	Downgrade	Needham	Buy → Hold
2024-05-30	Iniziato	Goldman	Buy
2024-02-01	Aggiornamento	Mizuho	Neutral → Buy
2023-07-19	Iniziato	Robert W. Baird	Outperform
2023-06-30	Iniziato	CL King	Buy
2023-05-30	Ripresa	Morgan Stanley	Overweight
2023-03-29	Iniziato	UBS	Buy
2022-12-22	Iniziato	Mizuho	Neutral
2022-12-20	Ripresa	Citigroup	Buy
2022-10-18	Iniziato	Barclays	Overweight
2022-10-12	Iniziato	Jefferies	Buy
2022-07-06	Iniziato	Wolfe Research	Outperform
2022-05-27	Aggiornamento	Needham	Hold → Buy
2022-04-13	Ripresa	Truist	Buy
2022-03-02	Ripresa	BofA Securities	Buy
2021-12-10	Iniziato	RBC Capital Mkts	Outperform
2021-05-26	Downgrade	Needham	Buy → Hold
2021-05-25	Iniziato	Barclays	Overweight
2021-04-15	Iniziato	Atlantic Equities	Overweight
2020-09-17	Iniziato	Truist	Buy
2020-09-11	Iniziato	Wolfe Research	Peer Perform
2020-04-22	Downgrade	SVB Leerink	Outperform → Mkt Perform
2020-04-01	Aggiornamento	Goldman	Neutral → Buy
2020-03-05	Iniziato	Citigroup	Buy
2020-02-13	Iniziato	Goldman	Neutral
2020-02-06	Ripresa	BTIG Research	Buy
2019-12-30	Reiterato	Cowen	Outperform
2019-12-19	Downgrade	Needham	Strong Buy → Buy
2019-09-05	Ripresa	JP Morgan	Overweight
2019-09-03	Ripresa	Barclays	Overweight
2019-05-13	Aggiornamento	Evercore ISI	In-line → Outperform
2018-11-28	Iniziato	UBS	Buy
2018-10-16	Iniziato	Barclays	Overweight
2018-10-02	Reiterato	Morgan Stanley	Overweight
2018-09-07	Reiterato	Needham	Strong Buy
2018-09-04	Aggiornamento	Jefferies	Hold → Buy
2018-07-06	Reiterato	Needham	Strong Buy
2018-06-27	Iniziato	Bernstein	Outperform
2018-04-26	Reiterato	Needham	Strong Buy

Mostra tutto

Boston Scientific Corp Borsa (BSX) Ultime notizie

11:05 AM

Q4 Earnings Highlights: Boston Scientific (NYSE:BSX) Vs The Rest Of The Medical Devices & SuppliesDiversified Stocks - Finviz

11:05 AM

Feb 24, 2026

Boston Scientific Adds Starbucks And Takeda Leaders To Guide Capital And Growth - Yahoo Finance

Feb 24, 2026

Boston Scientific adds Starbucks CFO, Takeda CEO to board amid $14.5B buying spree - The Business Journals

Feb 24, 2026

Boston Scientific adds Starbucks CFO and biopharma giant CEO to board - Worcester Business Journal

Feb 24, 2026

Feb 23, 2026

Boston Scientific (BSX) Expands Board and Increases Stock Repurc - GuruFocus

Feb 23, 2026

Boston Scientific (BSX) Increases Stock Buyback Program by $4 Bi - GuruFocus

Feb 23, 2026

Boston Scientific (BSX) expands board, approves $5.0B share repurchase plan - Stock Titan

Feb 23, 2026

Here is Why Boston Scientific Corporation (BSX) is Highly Favored by Hedge Funds - Insider Monkey

Feb 23, 2026

Global Neuromodulation Devices Market Anticipating Remarkable Growth at a CAGR of ~9% by 2032 | DelveInsight - GlobeNewswire Inc.

Feb 23, 2026

Former Boston Scientific Executive Joins Ceryx Medical’s Board - Medical Product Outsourcing

Feb 23, 2026

Penumbra earnings on deck as Boston Scientific deal looms By Investing.com - Investing.com South Africa

Feb 23, 2026

Penumbra earnings on deck as Boston Scientific deal looms - Investing.com

Feb 23, 2026

Boston Scientific elects Cathy Smith and Christophe Weber to Board of Directors - Finviz

Feb 23, 2026

Tredje AP fonden Has $104.53 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat

Feb 21, 2026

King Luther Capital Management Corp Grows Stake in Boston Scientific Corporation $BSX - MarketBeat

Feb 21, 2026

Fiera Capital Corp Takes Position in Boston Scientific Corporation $BSX - MarketBeat

Feb 21, 2026

Feb 20, 2026

Boston Scientific Stock is Down 20% This Year. Here Is What Investors Need to Know Before March 28 - TIKR.com

Feb 20, 2026

BSX vs. ABT: Which MedTech Stock is the Better Investment Now? - Finviz

Feb 20, 2026

Feb 19, 2026